Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Purpose To assess the impact on visual acuity of delays between diagnosis and treatment in patients with subfoveal neovascular age-related macular degeneration (NV-AMD) and to evaluate NV-AMD patients' emotional status before therapy initiation. Methods This retrospective, multicenter, epidemiological study included newly diagnosed NV-AMD patients registered in the Spanish national health system and referred to regional health centers for evaluation/treatment by a retinal specialist from 09/2005 to 03/2006. Records were reviewed and data abstracted at referring physicians' offices (diagnosis visit) and regional health centers (treatment visit). Treatment was at physicians' discretion. The Hospital Anxiety and Depression Scale was administered at the treatment visit (before therapy). Results Median time from the diagnosis to treatment visit was 2.3 months (95% confidence interval: 0.2-10.8 months). Vision loss had progressed at the treatment visit with a doubling in the percentage of patients with a visual acuity of 20/400 or worse (from 12.4 to 24.7%). The decrease in visual acuity from the diagnosis to the treatment visit was highly statistically significant (P Conclusions Delayed treatment of patients newly diagnosed with NV-AMD is associated with substantial visual acuity loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar delay in access to services has been recorded in Canada, 67 Spain 68 and Germany.69,70”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [68]
Citations
Cites
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S. L., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,093
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Brody, B. L., Gamst, A. C., Williams, R. A., Smith, A. R., Lau, P. W., Dolnak, D., Rapaport, M. H., Kaplan, R. M., & Brown, S. I. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00754-0 · Cited by 581
(1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080090044025 · Cited by 495
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
The Psychosocial Impact of Macular Degeneration
Williams, R. A. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.4.514 · Cited by 423
Incidence and progression rates of age-related maculopathy: the Rotterdam Study.
Klaver, C. C. W., Assink, J. J. M., van Leeuwen, R., Wolfs, R. C. W., Vingerling, J. R., Stijnen, T., Hofman, A., & de Jong, P. T. (2001) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 353
Cited by
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355
Mitchell, P., Korobelnik, J.-F., Lanzetta, P., Holz, F. G., Prunte, C., Schmidt-Erfurth, U., Tano, Y., & Wolf, S. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.159160 · Cited by 295
Lim, J. H., Wickremasinghe, S. S., Xie, J., Chauhan, D. S., Baird, P. N., Robman, L. D., Hageman, G., & Guymer, R. H. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.09.013 · Cited by 141
Larsen, M., Waldstein, S. M., Boscia, F., Gerding, H., Monés, J., Tadayoni, R., Priglinger, S. G., Wenzel, A., Barnes, E., Pilz, S., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.011 · Cited by 103
Tadayoni, R., Waldstein, S. M., Boscia, F., Gerding, H., Pearce, I., Priglinger, S. G., Wenzel, A., Barnes, E., Gekkieva, M., Pilz, S., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.030 · Cited by 98
Kim, J. H., Chang, Y. S., Kim, J. W., Kim, C. G., Yoo, S. J., & Cho, H. J. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.004 · Cited by 94
Muether, P. S., Hermann, M. M., Koch, K. R., & Fauser, S. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1520-9 · Cited by 81
Erratum: Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M. K., Chakravarthy, U., Gale, R. P., Gavin, M., Ghanchi, F. D., Gibson, J., Harding, S. P., Johnston, R. L., Kelly, S. P., Lotery, A. J., et al. (2015) · Eye · doi:10.1038/eye.2015.159 · Cited by 59
Wickremasinghe, S. S., Xie, J., Lim, J., Chauhan, D. S., Robman, L., Richardson, A. J., Hageman, G., Baird, P. N., & Guymer, R. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6550 · Cited by 58
Age-Related Macular Degeneration: A Complementopathy?
Kijlstra, A., & Berendschot, T. T. J. M. (2015) · Ophthalmic Research · doi:10.1159/000432401 · Cited by 49
Ong, A. Y., Taribagil, P., Sevgi, M., Kale, A. U., Dow, E. R., Macdonald, T., Kras, A., Maniatopoulos, G., Liu, X., Keane, P. A., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01726-8 · Cited by 46
The Burden of Macular Diseases in Central and Eastern Europe—Implications for Healthcare Systems
Mekjavič, P. J., Balčiūnienė, V. J., Ćeklić, L., Ernest, J., Jamrichova, Z., Nagy, Z. Z., Petkova, I., Teper, S. J., Topčić, I. G., & Veith, M. (2019) · Value in Health Regional Issues · doi:10.1016/j.vhri.2018.11.002 · Cited by 44
Hernández-Pastor, L. J., Ortega, A., García‐Layana, A., & Giráldez, J. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1156-9 · Cited by 40
Kumar, A., Sahni, J., Stangos, A. N., Campa, C., & Harding, S. P. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.171868 · Cited by 36
Hernández-Pastor, L. J., Ortega, A., García‐Layana, A., & Giráldez, J. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.025 · Cited by 36
Clinically Relevant Symptoms of Anxiety and Depression in Low-Vision Community-Living Older Adults
Kempen, G. I. J. M., & Zijlstra, G. A. R. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.08.007 · Cited by 34
Talks, J. S., Daïen, V., Finger, R. P., Eldem, B. M., Sakamoto, T., Cardillo, J. A., Mitchell, P., Wong, T. Y., & Korobelnik, J. (2019) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2019.02.008 · Cited by 32
Han, F., Chen, & Han, F. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s32801 · Cited by 28
Cost-Effectiveness of Preoperative OCT in Cataract Evaluation for Multifocal Intraocular Lens
Leung, E. H., Gibbons, A. G., & Koch, D. D. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.01.049 · Cited by 24
Wei, W., Weisberger, A., Zhu, L., Cheng, Y., & Liu, C. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.08.001 · Cited by 24
Gründe für Therapieverzögerung und -abbruch bei altersabhängiger Makuladegeneration
Wintergerst, M. W. M., Bouws, J., Loss, J., Heimes, B., Pauleikhoff, D., Holz, F. G., & Finger, R. P. (2017) · Der Ophthalmologe · doi:10.1007/s00347-017-0610-z · Cited by 22
Burton, A. E., Shaw, R. L., & Gibson, J. M. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003306 · Cited by 21
What is new in the management of wet age-related macular degeneration?
Sivaprasad, S., & Hykin, P. G. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt004 · Cited by 20
Lee, T. G., Kim, J. H., Chang, Y. S., Kim, C. G., & Kim, J. W. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2624-4 · Cited by 20
Jiménez-Gómez, Y., Alba-Molina, D., Blanco-Blanco, M., Pérez-Fajardo, L., Reyes-Ortega, F., Ortega-Llamas, L., Villalba-González, M., Fernández-Choquet de Isla, I., Pugliese, F., Stoikow, I., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071473 · Cited by 19
Sim, P. Y., Gajree, S., Dhillon, B., & Borooah, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017771 · Cited by 19
Liu, L., & Swanson (2013) · Clinical Optometry · doi:10.2147/opto.s29932 · Cited by 17
Lotery, A. J., Clemens, A., Tuli, R., Xu, X., Shimura, M., Nardi, M., Ziemssen, F., Dunger‐Baldauf, C., Tadayoni, R., & on behalf of the LUMINOUS™ study group (2021) · Eye · doi:10.1038/s41433-021-01702-y · Cited by 16
Schalnus, R., Meyer, C. H., Kuhli-Hattenbach, C., & Lüchtenberg, M. (2009) · Ophthalmologica · doi:10.1159/000239236 · Cited by 15
SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY
Wong, D. T., Lambrou, G. N., Loewenstein, A., Pearce, I., & Okada, A. A. (2020) · Retina · doi:10.1097/iae.0000000000002713 · Cited by 15
Visual‐Function Tests for Self‐monitoring of Age‐Related Macular Degeneration
Liu, L., Wang, Y., & Bedell, H. E. (2014) · Optometry and Vision Science · doi:10.1097/opx.0000000000000324 · Cited by 14
Adrian, M. L., & Rung (2013) · Clinical ophthalmology · doi:10.2147/opth.s41585 · Cited by 14
UK Aflibercept Users Group, Talks, J. S., James, P., Sivaprasad, S., Johnston, R. L., & McKibbin, M. (2017) · Eye · doi:10.1038/eye.2017.86 · Cited by 13
Age-Related Macular Degeneration: A Guide for the Primary Care Physician
Hazin, R., Freeman, P. D., & Kahook, M. Y. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30825-7 · Cited by 12
A novel tool to assess the quality of RWE to guide the management of retinal disease
Finger, R. P., Daïen, V., Talks, J. S., Mitchell, P., Wong, T. Y., Sakamoto, T., Eldem, B. M., Lövestam‐Adrian, M., & Korobelnik, J. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14698 · Cited by 11
Özkaya, A., Alkın, Z., Osmanbaşoğlu, Ö. A., Özkaya, H. M., & Demirok, A. (2014) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2013.08.006 · Cited by 9
Keane, P. A., Tufail, A., & Patel, P. J. (2011) · Journal of Ophthalmology · doi:10.1155/2011/752543 · Cited by 8
Nguyen, V., Daïen, V., Guymer, R. H., McAllister, I. L., Morlet, N., Barthelmes, D., & Gillies, M. C. (2017) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13038 · Cited by 8
Long-Term Monitoring of Age-Related Macular Degeneration with Preferential Hyperacuity Perimetry
Stur, M., & Manor, Y. (2010) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20100830-05 · Cited by 7
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Rodríguez, P. M., Mateo, J., Esteban, O., Grijalbo, A. H., & Puyuelo, F. J. A. (2022) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-022-00401-z · Cited by 7
Nicolò, M., Ciucci, F., Nardi, M., Parolini, B., Russo, A., Scupola, A., Torregrossa, S., Vadalà, M., & on behalf of the PERSEUS-IT study investigators (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-022-05679-6 · Cited by 6
Upasani, D., & Dhingra, N. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2868_20 · Cited by 6
Korb, C. A., Zwiener, I., Lorenz, K., Mirshahi, A., Pfeiffer, N., & Stoffelns, B. M. (2013) · BMC Ophthalmology · doi:10.1186/1471-2415-13-84 · Cited by 6
Brankin, E., McCullagh, P. J., Patton, W. P., Muldrew, A., & Black, N. (2008) · International Machine Vision and Image Processing Conference (IMVIP) · doi:10.1109/imvip.2008.30 · Cited by 6
Kim, D. B., Kim, J. H., Jeong, S. H., Lee, T. G., Kim, J. W., Kim, C. G., Cho, S. W., Lee, D. W., & Han, J. I. (2013) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2013.54.11.1700 · Cited by 5
Tran, E., Maher, A., Basilious, A., & Malvankar‐Mehta, M. S. (2025) · Archives of Mental Health · doi:10.4103/amh.amh_80_24 · Cited by 4
Martínez-Castillo, R., González-Gallardo, C., Muñoz‐Ávila, J. I., Font, P., Villalba-González, M., Stoikow, I., de Isla, I. F.-C., Pugliese, F., Anaya-Alaminos, R., Garcia-Serrano, J. L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114368 · Cited by 4
Goldberg, R. A., Hill, L., Davis, T., & Quezada-Ruiz, C. (2021) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20210201-02 · Cited by 3
Özkaya, A., Alkın, Z., Özkaya, H. M., Ağca, A., Özgürhan, E. B., Karaküçük, Y., Yazici, A. T., & Demirok, A. (2013) · Journal of Ophthalmology · doi:10.1155/2013/786107 · Cited by 3
Chang, Y. S., Kim, J. H., Kim, J. W., Lee, T. G., & Kim, C. G. (2016) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2016.30.4.272 · Cited by 3
Improving treatment provision of Wet AMD with intravitreal ranibizumab
Ghazala, F. R., Hovan, M., & Mahmood, S. (2013) · BMJ Quality Improvement Reports · doi:10.1136/bmjquality.u201733.w993 · Cited by 3
Saleh, M., Kheliouen, M., Tebeanu, E., Ballonzoli, L., Bourcier, T., Speeg‐Schatz, C., & Gaucher, D. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2284-9 · Cited by 2
Paneerselvam, G. S., Wai, N. J., Lim, J.-S., & Lee, K. K. C. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101542 · Cited by 2
Subfoveal exudative age-related macular degeneration: evidence for preoccult disease
Shah, A. R., & Priore, L. V. D. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328329b669 · Cited by 1
Macular Diseases: Moving the Battlefield to the Patient's Home
Loewenstein, A. (2011) · Retina · doi:10.1097/iae.0b013e31822528ea · Cited by 1
Umetna inteligenca v obravnavi bolnika z boleznijo mrežnice
Koce, M., Mekjavič, P. J., Urbančič, M., Pompe, M. T., & Petrovič, M. G. (2022) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3259 · Cited by 1
Borse, N., Surti, R., Maksane, N., Bhavsar, M., & Thaker, M. (2020) · International Journal of Ophthalmology & Visual Science · doi:10.11648/j.ijovs.20200504.12 · Cited by 1
Real, J. P. (2016) · Americanae (AECID Library) · Cited by 1
Han, S. Y., Kim, J. W., Kim, C. G., Lee, D. W., Han, J. I., Yoo, S. J., & Kim, J. H. (2018) · Journal of Retina · doi:10.21561/jor.2018.3.2.57
Sandoval, M. A. A., & Ponce, L. A. A. (2015) · Americanae (AECID Library)
Jiang, S. (2014) · Texas ScholarWorks (Texas Digital Library)
Gershoni, A., Barayev, E., Daood, R. H., Yogev, M., Gal‐Or, O., Reitblat, O., Tsessler, M., Schaap‐Fogler, M., Tuuminen, R., & Ehrlich, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010111
Poveda, J. L., Arnáiz, P., López, S. G., Muñoz, B., & Fernández‐Ferreiro, A. (2025) · Pharmacy · doi:10.3390/pharmacy13030068
Self‐recognition of recurrences among patients with exudative age‐related macular degeneration
Kim, J. H., Chang, Y. S., Kim, J. W., Lee, D. W., Han, J. I., & Kim, C. G. (2016) · Clinical and Experimental Optometry · doi:10.1111/cxo.12315
Pitcher, J. D., Rahimy, E., Sherman, S., Silva, F. Q. D. P. A., Moini, H., Boucher, N., Engelhard, S. B., & Moshfeghi, A. A. (2026) · Ophthalmology Retina · doi:10.1016/j.oret.2026.09.029
Valverde-Megías, A. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Ong, A. Y., Chopra, R., Hogg, H. D. J., Denniston, A. K., & Keane, P. A. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101253
Retraso en el tratamiento de la degeneración macular asociada a la edad en España
González, R. A., Alberto-Pestano, M. M., Rubio-Rodríguez, G., & Reyes, P. A. (2017) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2016.12.016
Delay in age-related macular degeneration treatment in Spain
González, R. A., Alberto-Pestano, M. M., Rubio-Rodríguez, G., & Reyes, P. A. (2017) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2017.03.007
Anaya, L. J. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid)
Metadata
- Authors
- Arias, L., Armadá, F., Donate, J., García-Arumí, J., Giralt, J., Pazos, B., Piñero, A., Martínez, F., Mondéjar, J. J., Ortega, I., Zlateva, G., & Buggage, R.
- Affiliations
- Bellvitge University Hospital (ES)
- Hospital Universitario La Paz (ES)
- Universitat Autònoma de Barcelona (ES)
- Hospital Universitario de Valme (ES)
- Marqués de Valdecilla University Hospital (ES)
- Pfizer (United States) (US)
- Corresponding author
- Arias, L
- Venue
- Eye
- Published
- 2008-01-18
- Volume
- 23
- Issue
- 2
- Pages
- 326-333
- ISSN
- 0078-5334 (ISSN-L)
- 0950-222X
- 1476-5454
- OpenAlex
- W2024615783
- Cited by
- 67
- References
- 23
- Citations by year
- 2026: 2 · 2025: 4 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 12 · 2012: 2
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Eye (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- neovascular age-related macular degeneration, treatment delay, time from diagnosis to treatment, visual acuity loss, depression, anxiety, emotional state, lesion size
- MeSH terms
- Aged, Aged, 80 and over, Anxiety, Depression, Female, Humans, Macular Degeneration, Male, Retrospective Studies, Time Factors, Vision Disorders, Visual Acuity, Treatment Outcome, Disease Progression, Choroidal Neovascularization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.